PAPIMI Testimonials

Athlete suffering from chondropathia  after being treated with PAPIMI device 

plus chondroitine and glucozamine wins the Copper Medal !

by Dr. Nick Papandreou M.D.

Female athlete A.S 38 years old came in my practice a wile ago diagnosed as suffering from chondropathia of the knee

Patient was exposed in the pulsed magnetic field of the PAPIMI device around two or three times per week, for 30 minutes each time for one year. During this treatment she received also chondroitine and glucozamine as food supplements.

The results were outstanding, since in the athletic event  "Olympus Marathon 2007" she won the Copper Medal !

----------------------------------------------------------------------------------------------------------------------------------

Application of PAPIMI device and antioxidants to primary hepatoma

by Dr. Nick Papandreou MD.

A 88 years old male patient came to my practice about one and a half year ago diagnosed with primary hepatoma. From then on, he has been exposed to the pulsed magnetic field of PAPIMI device three times per week, for 30 minutes each time and at the same time he was taking vitamins and antioxidants as food supplements.

Here follows a partial record of the observed findings :

Date	Examination	Findings
08/08/2006	Calculating Tomography	Liver tissue formation 8cm diameter
22/09/2006	A-Fetoprotein (AFP)	60500,0 ng / ml (reference values: 0,0  – 15,0)
07/11/2006	A-Fetoprotein (a-FP)	39,5   μg / ml   (reference values : < 10  ng/ml)
07/11/2006	Liver Ultrasonogram	Liver tissue formation 7,9 cm diameter
06/02/2007	Triplex	Liver tissue formation diameter 52,8 mm
06/02/2007	A-Fetoprotein  (a-FP)	364,8     (reference values : <  7,0 ng/ml)
07/02/2007	Liver Ultrasonic Control 4D	Liver tissue formation 3,9 X 3,2 cm diameter
09/05/2007	Liver Ultrasonic Control 4D	Liver tissue formation diameter 21,8 mm
09/05/2007	A - FP	22,45 ng / ml    (reference values:   < 10)
09/05/2007	CA 19-9	9,16 IU / ml      (reference values:  <  39,0 )
09/05/2007	C.E.A	2,77 ng / ml     (reference values:   <  5)
18/7/2007	A-Fetoprotein (AFP)	10,9  ng / ml      (reference values: 0,0  – 15,0)
18/7/2007	CA 19-9	6,6    IU / ml      (reference values        < 39,0 )
18/7/2007	CEA	2,2   ng / ml       (reference values   0,0  – 5,0 )
18/7/2007	Calculating Tomography	Liver tissue formation 3 cm maximum diameter
10/10/2007	AFP	18,4   ng / ml    (reference values: 0 - 8,1)
10/10/2007	CA 19.9	4,9    U / ml    (reference values:  0 - 37  )
10/10/2007	CEA	1,32 ng / ml    (reference values:  < 5 )
12/10/2007	Ultrasonic Control 4D	Liver tissue formation 2,9 mm maximum diameter and volume 9,4 ml
16/11/2007	Ultrasonogram of the upper abdomen	Liver tissue formation 4,75 X 2,19 cm
02/01/2008	Calculating Tomography	Liver tissue formation 20 mm maximum diameter
07/01/2008	Ultrasonic Control 4D	Liver tissue formation of maximum diameter 2,9 mm and volume 9,4 ml
07/01/2008	NF  – kB	3,144            ( reference value   < 18,368)
16/01/2008	AFP	54,2   ng / ml    (reference values: 0 - 8,1)
16/01/2008	CA 19.9	4,1    U / ml     (reference values: 0 - 37 )
16/01/2008	CEA	1,06  ng / ml    (reference values:   <  5)
23/01/2008	A-Fetoprotein (AFP)	56,0 ng / ml      (reference values: 0,0  – 15,0)

Comments :

Liver tissue formation - as measured by calculating tomography - has been reduced from a 8 cm diameter to a 2 cm maximum diameter within 17 months, that is from August 2006  to January 2008.

A - Fetoprotein has been reduced from 60500,0 ng/ml to 56,0 ng/ml within 16 months, that is from September 2006 to January 2008